Therapeutic Plasma Exchange in Multiple Sclerosis Patients with Abolished Interferon-beta Bioavailability

BACKGROUND: Neutralizing antibodies (NAb) to interferon-beta (IFN-β) are associated with reduced bioactivity and efficacy of IFN-β in multiple sclerosis (MS). The myxovirus resistance protein A (MxA) gene expression is one of the most appropriate markers of biological activity of exogenous IFN-β. We...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Med Sci Monit
Autors principals: Giedraitiene, Natasa, Kaubrys, Gintaras, Kizlaitiene, Rasa, Bagdonatė, Loreta, Griskevicius, Laimonas, Valceckiene, Vilma, Stoskus, Mindaugas
Format: Artigo
Idioma:Inglês
Publicat: International Scientific Literature, Inc. 2015
Matèries:
Clinical Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4456985/
https://ncbi.nlm.nih.gov/pubmed/26009248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.894119
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars